Ventyx Biosciences, Inc. (VTYX)

NASDAQ

$--

(--)

Pre-Market

Ventyx Biosciences, Inc. (VTYX) Live Price Chart

Last updated: ⁦2026-10-20 09:19:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Ventyx Biosciences, Inc. (VTYX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Ventyx Biosciences, Inc. (VTYX) Pre-Market Stock Price

Ventyx Biosciences, Inc. (VTYX) is trading at $-- in pre-market trading as of --, -- from the previous close of $--

Pre-market trading shows how investors are pricing VTYX before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.

Ventyx Biosciences, Inc. (VTYX) 7-Day Stock Price Change

Over the past seven days, Ventyx Biosciences, Inc. (VTYX) moved from $13.96 to $14.00, representing a gain of 0.29% ($0.04).

The stock traded between $13.94 and $14.00 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.

The average daily volume was 4.61 million shares, up versus the previous seven-day period, indicating higher trading activity.

What is Ventyx Biosciences, Inc. (VTYX)?

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

Ventyx Biosciences, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	81
Exchange	NASDAQ
Company Website	https://www.ventyxbio.com

How to Buy Ventyx Biosciences, Inc. (VTYX) Stock on MEXC

Eligible investors can buy real shares of Ventyx Biosciences, Inc. (VTYX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VTYX and Place Your Order

Open the RealStocks trading page and search for VTYX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Ventyx Biosciences, Inc. (VTYX) stock price today?

Ventyx Biosciences, Inc. (VTYX) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is VTYX stock going up or down today?

As of --, VTYX is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is VTYX pre-market price?

As of --, VTYX is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VTYX after-hours price?

As of --, VTYX is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is VTYX stock trading now?

VTYX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VTYX sit relative to its 52-week high and low?

Over the past 52 weeks, VTYX has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Ventyx Biosciences, Inc. in?

Ventyx Biosciences, Inc. (VTYX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Ventyx Biosciences, Inc.'s market capitalization and where is it listed?

Ventyx Biosciences, Inc. is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VTYX valued in terms of P/E ratio and EPS?

VTYX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Ventyx Biosciences, Inc. pay a dividend?

Ventyx Biosciences, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.